Antibody-based technique holds promise for children in "bubbles"

09/2/2009 | BBC

U.K. doctors have developed a technique that could eliminate the need for chemotherapy drugs to administer a bone marrow transplant in children suffering from primary immunodeficiencies, or genetic disorders affecting the immune system, and who must live in "bubbles," or sterile environments. The treatment uses an antibody, which homes in on a molecule linked to blood and bone cells, to wipe out a patient's bone marrow and provide space for donor stem cells.

View Full Article in:

BBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD